RLYB
Rallybio Corp
NASDAQ · Healthcare · Biotechnology · US
$15.90
+0.25%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 3.45x
- PEG TTM
- —
- Price / book
- 0.93x
- Price / sales
- 197.25x
- Price / cash flow
- 2.80x
Enterprise value
- Enterprise value
- -$5.1M
- EV / sales
- -11.72x
- EV / EBITDA
- -0.16x
- EV / EBIT
- 0.25x
- Market cap
- $85.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026